Biosimilars: Intellectual Property Creation and Protection by Pioneer and by...
Curator: Aviva Lev-Ari, PhD, RN For Financial Aspects of Biosimilars, go to: Biosimilars: Financials 2012 vs. 2008...
View ArticleUCSF Appeal of United States Patent and Trademark Office Judgment in Favor of...
Reporter: Aviva Lev-Ari, PhD, RN this post was reblogged on 9/28/2012 by...
View ArticleInnovators can exit with an idea: How to Monetizing Patents and ideas:...
Innovators can exit with an idea How to Monetizing Patents and ideas: yazamIP.com launches Idea Lab Reporter: Aviva Lev-Ari, PhD, RN The IDEA as Entry and as Exit Point 1. yazamIP.com launches Idea...
View ArticleProtecting Your Biotech IP and Market Strategy: Notes from Life Sciences...
Protecting Your Biotech IP and Market Strategy: Notes from Life Sciences Collaborative 2015 Meeting Achievement Beyond Regulatory Approval – Design for Commercial Success Stephen J. Williams, Ph.D.:...
View ArticleHow the ACLU Won the Fight Against Patenting Genes: Aritcles and video on the...
How the ACLU Won the Fight Against Patenting Genes: Article and video on the History of the Issue of Gene Patents Curator: Stephen J. Williams, PhD please see the TED talk below on how ACLU took on...
View ArticleStructure-guided Drug Discovery: (1) The Coronavirus 3CL hydrolase (Mpro)...
Structure-guided Drug Discovery: (1) The Coronavirus 3CL hydrolase (Mpro) enzyme (main protease) essential for proteolytic maturation of the virus and (2) viral protease, the RNA polymerase, the viral...
View ArticleOpenAI and ChatGPT face unique legal challenges over CopyRight Laws
OpenAI and ChatGPT face unique legal challenges over CopyRight Laws Reporter: Stephen J. Williams, PhD In previous weeks on this page and on the sister page ChatGPT applied to Cancer & Oncology, a...
View Article
More Pages to Explore .....